CASPR2 Antibody,Cell-based IFA

Other names: CASPR2 Antibody, Cell-based IFA

Negative

A negative CASPR2 Antibody, Cell-based IFA result means that no CASPR2 antibodies were detected in the blood at the time of testing.

Here's what that typically indicates:

  • Lower likelihood of CASPR2-related autoimmune disease: The result suggests that your symptoms are not caused by an autoimmune attack involving CASPR2.

  • However, it does not rule out all autoimmune or paraneoplastic conditions:

    • You may still have neurological symptoms caused by other autoantibodies not included in this specific test.

    • Some autoimmune disorders may occur without detectable antibodies early in the disease process.

What to do next:

If your symptoms persist or worsen, your healthcare provider may:

  • Recommend additional autoantibody testing (e.g., LGI1, NMDA receptor, or other paraneoplastic panels)

  • Order imaging (MRI, PET scan), spinal fluid analysis, or cancer screening depending on your clinical presentation

In summary:

A negative CASPR2 antibody result reduces the chance that your symptoms are related to CASPR2-associated autoimmune encephalitis or neuromyotonia—but further testing may still be needed to find the cause of your symptoms.

CASPR2 Antibody, Cell-based IFA

What is the CASPR2 Antibody Test?

The CASPR2 Antibody, Cell-based IFA test looks for specific autoantibodies that target a protein called CASPR2 (Contactin-associated protein-like 2). This protein is found on nerve cells and plays an important role in how signals are transmitted in the brain and nervous system.

The presence of CASPR2 antibodies in the blood can indicate that the immune system is mistakenly attacking the nervous system—often as part of an autoimmune condition. In some cases, these antibodies may also be associated with certain types of cancer.

Why is this test done?

Doctors may order the CASPR2 antibody test if you are experiencing unexplained neurological symptoms, such as:

  • Memory loss or confusion

  • Seizures

  • Muscle stiffness or spasms

  • Difficulty walking or with coordination

  • Pain, numbness, or weakness

This test helps detect autoimmune or paraneoplastic neurological syndromes, which are rare but serious conditions caused by an immune response, sometimes triggered by cancer.

What does a positive result mean?

A positive CASPR2 antibody result suggests that your symptoms may be related to an autoimmune reaction affecting your nervous system. This can occur with or without an underlying cancer. Conditions linked to CASPR2 antibodies include:

  • Autoimmune encephalitis (inflammation of the brain)

  • Peripheral nerve hyperexcitability (neuromyotonia)

  • Morvan syndrome

  • Rarely, paraneoplastic syndromes associated with tumors (such as thymoma or lung cancer)

Your healthcare provider may recommend further tests—such as MRI, lumbar puncture, or cancer screening—to better understand the cause of your symptoms.

What does a negative result mean?

A negative result means no CASPR2 antibodies were detected. However, it does not completely rule out autoimmune or paraneoplastic conditions. If your symptoms continue, your doctor may consider other antibody tests or additional evaluations.

Test Method

This test is performed using a cell-based indirect immunofluorescence assay (IFA). It’s a sensitive and specific method that detects antibodies by observing how they bind to CASPR2 proteins on lab-grown cells under a microscope.

Takeaway

The CASPR2 Antibody test is a valuable tool for identifying autoimmune-related neurological disorders and may provide clues to underlying conditions such as cancer. Early diagnosis and treatment can improve outcomes and help manage symptoms more effectively.

CASPR2 Antibody,Cell-based IFA
Healthmatters dashboard showing biomarker trend graph

Every lab result you’ve ever had, charted and explained.

Healthmatters is a tracker for your lab results. Upload a report from any lab, any country — every marker charted and explained.

Start with my report →
Beyond CASPR2 Antibody,Cell-based IFA — 10,000+ markers explained
One CASPR2 Antibody,Cell-based IFA result tells you where you are. Your history tells you where you’re heading. Upload your past lab reports and see this marker — and every marker on them —every marker charted against your own lab’s ranges.
Start with this report →
Healthmatters timeline preview showing biomarker trends over time
Clinical Sources & References

All our content is backed by peer-reviewed studies, academic research, and trusted medical sources. We’re committed to accuracy and transparency — see our editorial policy for details.

Article Review Log
Written by Healthmatters Editorial Team
Healthmatters Lifetime Plan

Pay $250. Track your health forever

One payment. No renewals. Yours for life.

10,000+ biomarkers explained · trends over time

See other plans →
Secure checkout via Stripe · GDPR & HIPAA
We accept results from any lab
LabCorp Quest Diagnostics Genova Diagnostics DUTCH Test Doctor's Data Vibrant America ZRT Laboratory Cyrex Labs + any other lab

What members are saying

★★★★★ 10,000+ happy members
★★★★★

"Watching my numbers move over the years — instead of forgetting last time's results — completely changed how I manage my health."

Daniel
Member since 2022
★★★★★

"Living across several countries made keeping my lab results organized a real challenge. Healthmatters brought my results from the USA, Spain, and Germany together — 20 years of history, with long-term trends instead of scattered reports."

Ben
Member since 2021 · tracks across countries
★★★★★

"Standard lab ranges are too wide for how I practice — 'normal' isn't optimal. I set my own bands, so a client sees yellow before a marker goes officially out of range. That's the conversation I want to be having."

Dr. Alexandra
Functional medicine · 6 yrs on Pro